UB Paderborn / Katalog / Suche / in CDI

1 – 16 von 16

Sortiert nach

Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions

Hepatology (Baltimore, Md.), 2012-10, Vol.56 (4), p.1391-1400

2012

Link zum Volltext

Verfügbarkeit prüfen

Long‐term exclusive zinc monotherapy in symptomatic Wilson disease: Experience in 17 patients

Hepatology (Baltimore, Md.), 2009-11, Vol.50 (5), p.1442-1452

2009

Link zum Volltext

Verfügbarkeit prüfen

Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial

Trials, 2012-08, Vol.13 (1), p.144-144, Article 144

2012

Link zum Volltext

Verfügbarkeit prüfen

Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers: results from a large cohort in the Netherlands

European journal of gastroenterology & hepatology, 2016-03, Vol.28 (3), p.352-359

2016

Link zum Volltext

Verfügbarkeit prüfen

Real-life data on the impact of successful downstaging in patients with hepatocellular carcinoma: A Dutch Multicenter Study

European journal of internal medicine, 2022-03, Vol.97, p.56-61

2022

Link zum Volltext

Verfügbarkeit prüfen

Early Endoscopic Retrograde Cholangiopancreatography Versus Conservative Management in Acute Biliary Pancreatitis Without Cholangitis : A Meta-Analysis of Randomized Trials

Annals of surgery, 2008-02, Vol.247 (2), p.250-257

2008

Link zum Volltext

Verfügbarkeit prüfen

Probiotics in primary sclerosing cholangitis: a randomized placebo-controlled crossover pilot study

European journal of gastroenterology & hepatology, 2008-07, Vol.20 (7), p.688-692

2008

Link zum Volltext

Verfügbarkeit prüfen

Real life adherence of chronic hepatitis B patients to entecavir treatment

Digestive and liver disease, 2015-07, Vol.47 (7), p.577-583

2015

Link zum Volltext

Verfügbarkeit prüfen

Small Gallstones Are Associated with Increased Risk of Acute Pancreatitis: Potential Benefits of Prophylactic Cholecystectomy?

The American journal of gastroenterology, 2005-11, Vol.100 (11), p.2540-2550

2005

Link zum Volltext

Verfügbarkeit prüfen

Ribavirin Concentration Is a More Important Predictor of Sustained Viral Response Than Anemia in Hepatitis C Patients

Gastroenterology (New York, N.Y. 1943), 2011-05, Vol.140 (5), p.1693-1694

2011

Link zum Volltext

Verfügbarkeit prüfen

Renal proximal tubular dysfunction due to tenofovir in a patient with chronic hepatitis B monoinfection

Clinics and research in hepatology and gastroenterology, 2015-10, Vol.39 (5), p.e67-e69

2015

Link zum Volltext

Verfügbarkeit prüfen

Measuring ribavirin concentrations during the earliest stages of antiviral therapy for hepatitis C: potential relevance for treatment outcome

Therapeutic drug monitoring, 2013-08, Vol.35 (4), p.546

2013

Link zum Volltext

Verfügbarkeit prüfen

Ursodeoxycholic acid exerts no beneficial effect in patients with symptomatic gallstones awaiting cholecystectomy

Hepatology (Baltimore, Md.), 2006-06, Vol.43 (6), p.1276-1283

2006

Link zum Volltext

Verfügbarkeit prüfen

T-cell responses at baseline and during therapy with peginterferon-α and ribavirin are not associated with outcome in chronic hepatitis C infected patients

Antiviral research, 2010-09, Vol.87 (3), p.353-360

2010

Link zum Volltext

Verfügbarkeit prüfen

Single or multiple dose ursodeoxycholic acid for cholestatic liver disease: biliary enrichment and biochemical response

Journal of hepatology, 1996-12, Vol.25 (6), p.887-894

1996

Link zum Volltext

Verfügbarkeit prüfen

Small gallstones and pancreatitis

Hepatology (Baltimore, Md.), 2005-09, Vol.42 (3), p.736; author reply 736-736

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 16 von 16

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect

ThemaTreatment Outcome

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(16)

Sprache

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions

Long‐term exclusive zinc monotherapy in symptomatic Wilson disease: Experience in 17 patients

Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial

Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers: results from a large cohort in the Netherlands

Real-life data on the impact of successful downstaging in patients with hepatocellular carcinoma: A Dutch Multicenter Study

Early Endoscopic Retrograde Cholangiopancreatography Versus Conservative Management in Acute Biliary Pancreatitis Without Cholangitis : A Meta-Analysis of Randomized Trials

Probiotics in primary sclerosing cholangitis: a randomized placebo-controlled crossover pilot study

Real life adherence of chronic hepatitis B patients to entecavir treatment

Small Gallstones Are Associated with Increased Risk of Acute Pancreatitis: Potential Benefits of Prophylactic Cholecystectomy?

Ribavirin Concentration Is a More Important Predictor of Sustained Viral Response Than Anemia in Hepatitis C Patients

Renal proximal tubular dysfunction due to tenofovir in a patient with chronic hepatitis B monoinfection

Measuring ribavirin concentrations during the earliest stages of antiviral therapy for hepatitis C: potential relevance for treatment outcome

Ursodeoxycholic acid exerts no beneficial effect in patients with symptomatic gallstones awaiting cholecystectomy

T-cell responses at baseline and during therapy with peginterferon-α and ribavirin are not associated with outcome in chronic hepatitis C infected patients

Single or multiple dose ursodeoxycholic acid for cholestatic liver disease: biliary enrichment and biochemical response

Small gallstones and pancreatitis

Aktive Filter

Suchergebnisse filtern